trial

The Effectiveness of Breathing Therapy in Patients With Schizophrenia

NCTId NCT07150507
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 68 (actual)
Sponsored by Ataturk University
Primary completion 2022-11-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
68 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2022-04-29
Primary completion
2022-11-15
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Session 1: Preparation SessionSession 2: Recognizing the IllnessSession 3: Treatment EvaluationSession 4: What is anger?Session 5: CommunicationSession 6: What is relaxation?Session 7: RelaxationSession 8: Evaluation

Sponsors

Ataturk UniversityLead Sponsor

Investigators

1
Mine Cengiz lecturer doctorPrincipal Investigator

Sites

1 total
Erzurum, Turkey (Türkiye)

Facts & assertions

4 sourced
Enrollment
68
Phase
NA
Primary Completion Date
2022-11-15
Status
COMPLETED
relationships
The graph out of here
drug
Session 1: Preparation Session
drug
Session 2: Recognizing the Illness
drug
Session 3: Treatment Evaluation
drug
Session 4: What is anger?
drug
Session 5: Communication
drug
Session 6: What is relaxation?
drug
Session 7: Relaxation
drug
Session 8: Evaluation
drug
lead_sponsor
Ataturk University
company
indication
Fatigue
indication
Breathing Therapy
indication
investigator
Mine Cengiz lecturer doctor
person